Regulations and Regulatory Issues

This article is intended to spark conversations about measurement uncertainty that lead to the recognition and application of effective uncertainty budgets in the cannabis arena.

George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.

The agencies sent warning letters to several companies that the agencies say are illegally marketing unapproved products to treat opioid addiction and withdrawal.